Company / Working Capital
TENAX THERAPEUTICS, INC. Working Capital History
FY2012-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$97.1M
FY2025
5-year range
$7.4M / $97.1M
FY2021-FY2025
Trend
+5.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $7M to $97M over the past 9 years.
Based on SEC 10-K filings.
$97M in FY2025 with a 10-year CAGR of +5.6%.
Improved from $7M to $97M over the past 9 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- +5.6%
Key checks
Key Insights
- In FY2025, working capital increased 5.5% year-over-year.
- Lowest working capital in the period was in FY2012.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.24 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $97.1M | +5.5% |
| FY2024 | $92.0M | +1138.3% |
| FY2016 | $7.4M | -86.8% |
| FY2015 | $56.4M | +0.0% |
| FY2014 | $56.4M | +83864.1% |
| FY2013 | -$67.3K | +86.4% |
| FY2012 | -$495.8K | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026